Healthcare of Ontario Pension Plan Trust Fund Has $84.96 Million Stake in Lam Research Corporation $LRCX

Healthcare of Ontario Pension Plan Trust Fund lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 45.2% during the fourth quarter, Holdings Channel.com reports. The firm owned 496,300 shares of the semiconductor company’s stock after selling 409,294 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Lam Research were worth $84,957,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in LRCX. Norges Bank bought a new position in shares of Lam Research during the fourth quarter worth approximately $3,645,427,000. Arrowstreet Capital Limited Partnership increased its stake in shares of Lam Research by 781.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock worth $1,518,542,000 after purchasing an additional 10,053,978 shares during the period. Franklin Resources Inc. increased its stake in shares of Lam Research by 57.0% during the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after purchasing an additional 3,671,073 shares during the period. Invesco Ltd. increased its stake in shares of Lam Research by 18.2% during the third quarter. Invesco Ltd. now owns 21,182,948 shares of the semiconductor company’s stock worth $2,836,397,000 after purchasing an additional 3,263,658 shares during the period. Finally, California Public Employees Retirement System increased its stake in shares of Lam Research by 108.7% during the third quarter. California Public Employees Retirement System now owns 4,526,099 shares of the semiconductor company’s stock worth $606,045,000 after purchasing an additional 2,356,897 shares during the period. Institutional investors own 84.61% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research is benefiting from renewed optimism around wafer-fab equipment demand, with management recently raising its 2026 WFE market forecast to $140 billion and analysts lifting price targets on expectations that AI-driven chip investment will stay strong. Article Title
• Positive Sentiment: Recent coverage highlighted Lam Research as a core beneficiary of the AI infrastructure boom, with Barclays reiterating constructive views on chip-equipment names and investors focusing on ongoing spending for new semiconductor supply. Article Title
• Positive Sentiment: Lam Research’s recent earnings outperformance and upbeat guidance continue to support the bullish case, with the company beating estimates and projecting stronger revenue momentum into upcoming quarters. Article Title
• Neutral Sentiment: Some recent pieces focus on valuation after the AI-driven rally, suggesting investors are now weighing how much upside is already priced in after a sharp run-up. Article Title
• Negative Sentiment: Broader semiconductor stocks have remained volatile, and one recent session saw LRCX fall more steeply than the market, showing that the stock can still be pressured by sector-wide AI and macro swings. Article Title

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Wells Fargo & Company reiterated an “overweight” rating and set a $575.00 target price (up from $320.00) on shares of Lam Research in a research note on Monday, June 1st. Needham & Company LLC reiterated a “buy” rating and set a $300.00 target price on shares of Lam Research in a research note on Thursday, April 23rd. Berenberg Bank increased their target price on Lam Research from $265.00 to $335.00 and gave the stock a “buy” rating in a research note on Thursday, April 23rd. Weiss Ratings lowered Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research note on Thursday, May 14th. Finally, HSBC increased their target price on Lam Research from $221.00 to $247.00 and gave the stock a “hold” rating in a research note on Friday, April 24th. Twenty-eight investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and a consensus price target of $322.01.

Insiders Place Their Bets

In other Lam Research news, insider Ava Harter sold 6,010 shares of the firm’s stock in a transaction on Monday, April 27th. The stock was sold at an average price of $258.66, for a total value of $1,554,546.60. Following the sale, the insider owned 53,205 shares of the company’s stock, valued at approximately $13,762,005.30. This trade represents a 10.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $309.60, for a total value of $2,371,226.40. Following the completion of the sale, the senior vice president directly owned 58,470 shares in the company, valued at approximately $18,102,312. This represents a 11.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 31,839 shares of company stock worth $8,561,667. Company insiders own 0.31% of the company’s stock.

Lam Research Stock Performance

Shares of NASDAQ:LRCX opened at $366.81 on Monday. The company has a market capitalization of $458.72 billion, a P/E ratio of 69.21, a P/E/G ratio of 3.02 and a beta of 1.85. Lam Research Corporation has a 1 year low of $87.75 and a 1 year high of $373.82. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. The business’s 50 day simple moving average is $286.10 and its 200 day simple moving average is $234.16.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. The business had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The firm’s quarterly revenue was up 23.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.04 earnings per share. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, research analysts anticipate that Lam Research Corporation will post 5.7 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Wednesday, June 17th. Lam Research’s dividend payout ratio (DPR) is currently 19.62%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.